Sea Mild Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	63.85	82.94	46.63	40.58	38.95	52.07
Cash & Short-Term Investments	63.85	82.94	46.63	40.58	38.95	52.07
Cash Growth	0.68%	77.89%	14.91%	4.19%	-25.20%	10.43%
Accounts Receivable	88.83	63.62	58.26	57.67	50.53	46.77
Other Receivables	-	-	-	-	-	2.18
Receivables	88.83	63.62	58.26	57.67	50.53	48.95
Inventory	51.21	58.01	28.81	16.77	21.14	28.59
Prepaid Expenses	3.29	3.1	7.16	1.38	2.47	3.6
Other Current Assets	6.77	8.74	9.99	6.99	0.03	24.45
Total Current Assets	213.94	216.42	150.84	123.39	113.11	157.65
Property, Plant & Equipment	42.09	24.9	23.2	27.29	43.23	72.32
Other Intangible Assets	-	-	0.03	0.31	0.71	1.68
Long-Term Deferred Tax Assets	0.91	0.91	1.86	1.81	1.7	11.75
Other Long-Term Assets	24.99	13.89	14.44	4.88	9.5	5.64
Total Assets	281.93	256.11	190.36	157.69	168.23	249.04
Accounts Payable	55.18	65.24	50.32	46.48	37.37	41.18
Accrued Expenses	9.49	14.37	8.46	7.35	8.11	8.97
Short-Term Debt	30	30	25	3.05	-	-
Current Portion of Long-Term Debt	18.84	16.67	-	-	-	-
Current Portion of Leases	6.85	6.83	12.91	10.65	7.84	10.23
Current Unearned Revenue	0.51	0.61	0.33	0.65	1.38	15.03
Other Current Liabilities	19.95	16.06	16.6	13.36	10.4	11.96
Total Current Liabilities	140.81	149.78	113.61	81.55	65.1	87.37
Long-Term Debt	15.53	3.33	-	-	-	-
Long-Term Leases	17.93	0.59	6.34	11.65	17.32	23.81
Long-Term Deferred Tax Liabilities	-	-	0	0.02	-	-
Other Long-Term Liabilities	0.01	0.01	-	-	-	-
Total Liabilities	174.29	153.71	119.96	93.21	82.41	111.18
Common Stock	193.09	193.09	193.09	193.09	193.09	193.09
Retained Earnings	-85.45	-90.7	-122.68	-128.87	-107.49	-55.44
Comprehensive Income & Other	-	-	-	0.27	0.22	0.21
Total Common Equity	107.64	102.39	70.41	64.48	85.82	137.86
Shareholders' Equity	107.64	102.39	70.41	64.48	85.82	137.86
Total Liabilities & Equity	281.93	256.11	190.36	157.69	168.23	249.04
Total Debt	89.15	57.42	44.25	25.35	25.16	34.04
Net Cash (Debt)	-25.3	25.52	2.38	15.23	13.79	18.03
Net Cash Growth	-	974.65%	-84.40%	10.45%	-23.54%	-
Net Cash Per Share	-1.31	1.32	0.12	0.79	0.71	0.93
Filing Date Shares Outstanding	19.31	19.31	19.31	19.31	19.31	19.31
Total Common Shares Outstanding	19.31	19.31	19.31	19.31	19.31	19.31
Working Capital	73.13	66.64	37.23	41.85	48.01	70.28
Book Value Per Share	5.57	5.30	3.65	3.34	4.44	7.14
Tangible Book Value	107.64	102.39	70.37	64.17	85.11	136.17
Tangible Book Value Per Share	5.57	5.30	3.64	3.32	4.41	7.05
Machinery	83.89	78.6	67.32	66.07	67.04	70.62

Source: S&P Global Market Intelligence. Standard template. Financial Sources.